A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait | MicrobiomeTrials← Back to trialsNCT07454850
A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-08-30Est. Completion: 2026-10-16
Enrollment target: 400 participants ContactNovartis Pharmaceuticals
Other microbiome trials you might be interested in
Leukemia, Chronic Myeloid
The aim of this study is to assess the real-world effectiveness of asciminib in Philadelphia chromosome-positive chronic…
Baden-Baden, GermanyEst. completion Sep 30, 2030
Malignancy, HematologicNeoplasms, HematologicNeoplasms, HematopoieticBlood CancerHematological NeoplasmsHematopoietic MalignanciesDysmyelopoietic SyndromesHematopoetic Myelodysplasia
Myeloid Leukemia, Acute
Nonlymphoblastic Leukemia, Acute
Leukemia, Lymphocytic, Acute
Background:
Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RA…
Bethesda, United StatesEst. completion Apr 30, 2029
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
The aim of this study is to support development of asciminib in the pediatric population (1 to \< 18 years) with Ph+ CML…
New Brunswick, United StatesEst. completion Feb 23, 2033